Atlas Trials

Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma

Clinical trial NCT02933073 · TERMINATED

Trial details

NCT number
NCT02933073
Sponsor
UConn Health
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2016-11-01
Primary completion
2022-08-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.